Joshua Reed | Chief Financial Officer |
Todd Brady | President and Chief Executive Officer |
Yigal Nochomovitz | Citigroup |
Marc Goodman | SVB Leerink |
Sung Ji Nam | BTIG |
Matthew Cross | Alliance Global Partners |
I-Eh Jen | Laidlaw & Company |
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics’ Full Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. I would now like to hand over the conference to the company's Chief Financial Officer, Mr. Joshua Reed.